Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
N K Cheung(Memorial Sloan Kettering Cancer Center), Nathan A. Berger(University School), Hillard M. Lazarus(University Hospitals Cleveland Medical Center), Floro Miraldi(Memorial Sloan Kettering Cancer Center), Ulla M. Saarinen(Memorial Sloan Kettering Cancer Center), Peter F. Coccia(North Central Cancer Treatment Group), Carlos R. Abramowsky(Memorial Sloan Kettering Cancer Center), Steven Kallick(Memorial Sloan Kettering Cancer Center), Sarah E. Strandjord(Memorial Sloan Kettering Cancer Center), Thomas R. Spitzer(Harvard University)
Cited by 415
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
|New England Journal of Medicine|2008|969
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907